Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 175.74M
March 31, 2026 219.39M
December 31, 2025 219.98M
September 30, 2025 231.60M
June 30, 2025 235.33M
March 31, 2025 247.07M
December 31, 2024 244.84M
September 30, 2024 195.35M
June 30, 2024 192.66M
March 31, 2024 243.15M
December 31, 2023 254.84M
September 30, 2023 158.38M
June 30, 2023 146.51M
March 31, 2023 183.92M
December 31, 2022 195.57M
September 30, 2022 204.22M
June 30, 2022 159.94M
March 31, 2022 184.55M
December 31, 2021 215.37M
September 30, 2021 135.56M
June 30, 2021 133.69M
March 31, 2021 138.77M
December 31, 2020 150.41M
September 30, 2020 141.42M
June 30, 2020 120.42M
Date Value
March 31, 2020 118.57M
December 31, 2019 199.30M
September 30, 2019 203.01M
June 30, 2019 203.09M
March 31, 2019 206.44M
December 31, 2018 203.92M
September 30, 2018 143.73M
June 30, 2018 128.34M
March 31, 2018 133.14M
December 31, 2017 167.48M
September 30, 2017 148.73M
June 30, 2017 156.03M
March 31, 2017 160.82M
December 31, 2016 187.82M
September 30, 2016 162.84M
June 30, 2016 201.67M
March 31, 2016 184.80M
December 31, 2015 204.89M
September 30, 2015 197.16M
June 30, 2015 182.46M
March 31, 2015 173.24M
December 31, 2014 166.39M
September 30, 2014 164.72M
June 30, 2014 209.47M
March 31, 2014 214.79M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics